Jan'05 | Jan'06 | Dec'06 | Dec'07 | Dec'08 | Jan'10 | Jan'11 | Jan'12 | Dec'12 | Dec'13 | Dec'14 | Jan'16 | Jan'17 | Dec'17 | Dec'18 | Dec'19 | Jan'21 | Jan'22 | Jan'23 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | $47.3B | $50.5B | $53.3B | $61.1B | $63.7B | $61.9B | $61.6B | $65.0B | $67.2B | $71.3B | $74.3B | $70.1B | $71.9B | $76.5B | $81.6B | $82.1B | $82.6B | $78.7B | $80.0B | $85.2B |
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
As of today, Johnson & Johnson's last 12-month Revenue is $87.7B, based on the financial report for Sep 29, 2024 (Q3 2024).
Over the last year, Johnson & Johnson's Revenue growth was 0.3%. The average annual Revenue growth rates for Johnson & Johnson have been 1.4% over the past three years, 1.4% over the past five years.
Over the last year, Johnson & Johnson's Revenue growth was 0.3%, which is higher than industry growth of 0.1%. It indicates that Johnson & Johnson's Revenue growth is Good.